Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II First-in-Human Study of TT-4 As a Single Agent in Participants with Advanced Selected Solid Tumors

NCT04976660 is registered in ClinicalTrials.gov with Tarus Therapeutics, Inc. as lead sponsor.

NCT NCT04976660
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04976660 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II First-in-Human Study of TT-4 As a Single Agent in Participants with Advanced Selected Solid Tumors
Lead sponsor
Tarus Therapeutics, Inc.
Phase
Phase 1/2
Overall status
Withdrawn
Start date
December 15, 2022
Completion date
September 30, 2023
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, gastric cancer, hepatocellular carcinoma, pancreatic cancer